Quantifying cardiovascular risk among patients with moderate to severe psoriasis

被引：0
|
作者：
Reich, K. [1 ]
Prinz, J. [2 ]
Szapary, P. [3 ]
Yeilding, N. [3 ]
Hsu, M. C. [3 ]
Li, S. [3 ]
Mrowietz, U. [4 ]
Kimball, A. B. [5 ]
Menter, A. [6 ]
机构：
[1] Univ Gottingen, Gottingen, Germany
[2] Univ Munich, Munich, Germany
[3] Centocor Res & Dev Inc, Malvern, PA USA
[4] Univ Kiel, Kiel, Germany
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Baylor Res Inst, Dallas, TX USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2008年 / 159卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1424 / 1424
页数：1
相关论文
共 50 条
  • [31] The effect of adalimumab on improving work productivity among moderate to severe psoriasis patients
    Kimball, Alexa B.
    Yu, Andrew P.
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB180 - AB180
  • [32] TREATMENT SATISFACTION AMONG PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL
    Lopes, N.
    Suarez, R. M.
    Sabbag, C. Y.
    Kobata, C. M.
    Takemoto, M. S.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [33] Adalimumab treatment for moderate psoriasis reduces the risk of transitioning to severe psoriasis
    Papp, Kim
    Signorovitch, James
    Mulani, Parvzez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [34] COST OF MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN
    Sanchez-Carazo, J. L.
    Dauden, E.
    Vanaclocha, F.
    Toribio, J.
    Pujol, R.
    Puig, L.
    Yebenes, M.
    Sabater, F. J.
    VALUE IN HEALTH, 2009, 12 (07) : A454 - A454
  • [35] Costeffectiveness of alefacept in patients with moderate to severe psoriasis
    Jorstad, IC
    Haugli, K
    Eggen, E
    Kristiansen, IS
    VALUE IN HEALTH, 2003, 6 (06) : 788 - 788
  • [36] Treatment changes in patients with moderate to severe psoriasis
    Anderson, Kathryn
    Feldman, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB256 - AB256
  • [37] Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency
    Richard Haynes
    Jane Armitage
    Nature Clinical Practice Nephrology, 2007, 3 : 530 - 531
  • [38] Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency
    Haynes, Richard
    Armitage, Jane
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (10): : 530 - 531
  • [39] Cardiovascular risk in psoriasis patients
    Dickison, P.
    Peek, J. J.
    Swain, G.
    Lee, A.
    Harris, V.
    Smith, S. D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 51 - 52
  • [40] Cardiovascular Risk in Patients With Psoriasis
    Garshick, Michael S.
    Ward, Nicole L.
    Krueger, James G.
    Berger, Jeffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 77 (13) : 1670 - 1680
12345